Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Omnicell
(NASDAQ:OMCL)
Intraday
$29.24
0
[0.00%]
After-Hours
$29.24
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$29.24
0
[0.00%]
At close: Mar 27
$29.24
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Omnicell Stock (NASDAQ:OMCL)
Omnicell Stock (NASDAQ: OMCL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 09, 2024
Benchmark Maintains Buy on Omnicell, Lowers Price Target to $38
Benzinga Newsdesk
-
Feb 9, 2024, 2:34PM
Wells Fargo Maintains Equal-Weight on Omnicell, Lowers Price Target to $26
Benzinga Newsdesk
-
Feb 9, 2024, 9:30AM
Thursday, February 08, 2024
Omnicell shares are trading lower after the company reported fourth-quarter financial results and issued guidance below estimates.
Benzinga Newsdesk
-
Feb 8, 2024, 8:08AM
Omnicell Expects Q1 Revenue of $232M-$242M Vs $262.37M Est, Adj EPS of ($0.10)-$0.00 Vs $0.31 Est, FY24 Revenue of $1.045B-$1.120B Vs $1.08B Est, Adj EPS of $0.90-$1.40 Vs $1.66 Est
Benzinga Newsdesk
-
Feb 8, 2024, 8:05AM
Omnicell Q4 Adj EPS $0.33 Beats $0.15 Estimate, Sales $258.85M Beat $255.56M Estimate
Benzinga Newsdesk
-
Feb 8, 2024, 8:02AM
Earnings Scheduled For February 8, 2024
Benzinga Insights
-
Feb 8, 2024, 4:43AM
Friday, November 03, 2023
Piper Sandler Upgrades Omnicell: Here's What You Need To Know
Benzinga Insights
-
Nov 3, 2023, 1:00PM
Wells Fargo Upgrades Omnicell to Equal-Weight, Lowers Price Target to $28
Benzinga Newsdesk
-
Nov 3, 2023, 8:04AM
BTIG Downgrades Omnicell to Neutral
Benzinga Newsdesk
-
Nov 3, 2023, 4:39AM
Piper Sandler Upgrades Omnicell to Overweight, Lowers Price Target to $39
Benzinga Newsdesk
-
Nov 3, 2023, 4:33AM
Thursday, November 02, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 2, 2023, 2:26PM
Omnicell Announces Headcount Reduction, Expects $12M-$18M In Non-Recurring Costs
Benzinga Newsdesk
-
Nov 2, 2023, 8:39AM
Omnicell Sees Q4 2023 Revenue $247M-$267M Vs $299.67M Est
Benzinga Newsdesk
-
Nov 2, 2023, 8:38AM
Omnicell Sees FY23 Bookings $850M-$950M, Sees Revenues $1.135B-$1.155B Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 8:38AM
Omnicell Q3 2023 Adj. EPS $0.62 Beats $0.47 Estimate, Revenue $299M Beats $295.47M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 8:05AM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Wednesday, October 11, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
Benzinga Insights
-
Oct 11, 2023, 11:00AM
Keybanc Downgrades Omnicell to Sector Weight
Benzinga Newsdesk
-
Oct 11, 2023, 5:28AM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Tuesday, October 03, 2023
Analyst Expectations for Omnicell's Future
Benzinga Insights
-
Oct 3, 2023, 1:00PM
Benchmark Maintains Buy on Omnicell, Lowers Price Target to $70
Benzinga Newsdesk
-
Oct 3, 2023, 11:44AM
Tuesday, September 26, 2023
Wells Fargo Maintains Underweight on Omnicell, Lowers Price Target to $39
Benzinga Newsdesk
-
Sep 26, 2023, 12:13PM
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 26, 2023, 12:04PM
Wednesday, August 30, 2023
Omnicell Inc. Unusual Options Activity: Slightly OTM Call Buying With Relative Size
Dara Akhavein
-
Aug 30, 2023, 2:20PM
Friday, August 04, 2023
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $75
Benzinga Newsdesk
-
Aug 4, 2023, 4:34AM
Wednesday, August 02, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 11:00AM
Benchmark Reiterates Buy on Omnicell, Maintains $88 Price Target
Benzinga Newsdesk
-
Aug 2, 2023, 10:30AM
Piper Sandler Downgrades Omnicell to Neutral, Raises Price Target to $70
Benzinga Newsdesk
-
Aug 2, 2023, 6:35AM
Tuesday, August 01, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Aug 1, 2023, 5:32PM
Omnicell Q2 Adj EPS $0.57 Beats $0.28 Estimate, Sales $298.97M Beat $284.57M Estimate
Benzinga Newsdesk
-
Aug 1, 2023, 4:04PM
Earnings Scheduled For August 1, 2023
Benzinga Insights
-
Aug 1, 2023, 4:06AM
Monday, July 31, 2023
Benchmark Reiterates Buy on Omnicell, Maintains $88 Price Target
Benzinga Newsdesk
-
Jul 31, 2023, 8:52AM
Thursday, July 20, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023
Benzinga Insights
-
Jul 20, 2023, 11:00AM
4 Analysts Have This to Say About Omnicell
Benzinga Insights
-
Jul 20, 2023, 8:00AM
Wells Fargo Downgrades Omnicell to Underweight, Lowers Price Target to $56
Benzinga Newsdesk
-
Jul 20, 2023, 5:55AM
Thursday, July 13, 2023
Keybanc Maintains Overweight on Omnicell, Raises Price Target to $80
Benzinga Newsdesk
-
Jul 13, 2023, 4:40AM
Wednesday, July 12, 2023
Top Investment Bank Unveils 3 ETFs, 10 Stocks To Buy In The AI Boom
Piero Cingari
-
Jul 12, 2023, 4:18PM
Thursday, June 15, 2023
Benchmark Maintains Buy on Omnicell, Raises Price Target to $88
Benzinga Newsdesk
-
Jun 15, 2023, 8:15AM
Monday, May 15, 2023
Omnicell Names Nchacha E. Etta As CFO, Effective June 1, 2023
Benzinga Newsdesk
-
May 15, 2023, 4:06PM
Wednesday, May 03, 2023
Omnicell shares are trading higher after the company reported better-than-expected Q1 sales results.
Benzinga Newsdesk
-
May 3, 2023, 10:55AM
Keybanc Maintains Overweight on Omnicell, Raises Price Target to $70
Benzinga Newsdesk
-
May 3, 2023, 4:11AM
Tuesday, May 02, 2023
Omnicell FY23 Guidance Is Unchanged
Benzinga Newsdesk
-
May 2, 2023, 4:03PM
Omnicell Q1 EPS $0.39 Down From $0.83 YoY, Sales $290.63M Beat $277.67M Estimate
Benzinga Newsdesk
-
May 2, 2023, 4:03PM
Thursday, March 02, 2023
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65
Benzinga Newsdesk
-
Mar 2, 2023, 4:42AM
Wednesday, March 01, 2023
Analyst Expectations for Omnicell's Future
Benzinga Insights
-
Mar 1, 2023, 3:01PM
Benchmark Reiterates Buy on Omnicell, Maintains $68 Price Target
Benzinga Newsdesk
-
Mar 1, 2023, 9:46AM
Tuesday, February 28, 2023
Omnicell Says Expects To Further Reduce Workforce Across Many Of Its Functions Affecting Approximately 60 Additional Employees
Michael Horton
-
Feb 28, 2023, 4:39PM
Omnicell Chief Financial Officer Peter J. Kuipers To Step Down Effective July 1, 2023
Happy Mohamed
-
Feb 28, 2023, 4:05PM
Omnicell Q4 EPS $0.33 Beats $0.09 Estimate, Sales $297.67M Beat $287.16M Estimate
Happy Mohamed
-
Feb 28, 2023, 4:03PM
Earnings Scheduled For February 28, 2023
Benzinga Insights
-
Feb 28, 2023, 4:34AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch